Jorgensen is set to testify before a Senate committee on Tuesday in a hearing focused on U.S. prices for its widely popular ...

Good evening! The last full-size Kmart store in the United States is closing. On a brighter note, the Philadelphia Phillies ...

Megyn Kelly criticized Oprah Winfrey's town hall event with Kamala Harris, claiming Winfrey is no longer the genuine figure ...

Lawmakers are set to scrutinize the high cost of weight loss and diabetes drugs, which depending upon your insurance can ...

The CEO of Novo Nordisk will testify in the Senate HELP Committee tomorrow about the cost of popular diabetes and weight loss ...

As the Senate Committee on Health, Education, Labor and Pensions (HELP) gears up for a hearing tomorrow titled “Why Is Novo ...

Hearing on weight loss drug prices will feature CEO of Novo Nordisk and comes after threats to subpoena company executives.

It's the second lawsuit to be filed this year in Maine against insurance carriers that limit coverage of popular drugs like ...

Novo Nordisk braced for a congressional inquiry into the high prices of weight loss and diabetes drugs, particularly Ozempic, ...

A Senate Committee on Health, Education, Labor and Pension hearing scheduled for Tuesday has all the makings of a showdown as ...

If confirmed, he would be the first person to serve in this position which was created in 2022. Novo Nordisk CEO Lars Jergensen testified on the company's pricing for its diabetes and weight loss ...

According to the Journal, the GLP-1 "pricing fight" began in late 2023, when Lilly priced Zepbound at $1,060 per month, or 20% lower than Novo Nordisk's Wegovy. Analysts told the newspaper that prices ...